Presentation is loading. Please wait.

Presentation is loading. Please wait.

Disclosure belangen NHG spreker

Similar presentations


Presentation on theme: "Disclosure belangen NHG spreker"— Presentation transcript:

1

2 Disclosure belangen NHG spreker
(Potentiële) belangenverstrengeling None Voor bijeenkomst mogelijk relevante relaties met bedrijven Sponsoring of onderzoeksgeld Honorarium of andere (financiële) vergoeding Aandeelhouder Andere relatie, namelijk …

3 Reduced mortality and subsequent fracture risk associated with oral bisphosphonate treatment
Tineke van Geel Dana Bliuc, Piet Geusens, Jacqueline Center, Geert-Jan Dinant, Thach Tran, Joop vd Bergh, Alastair McLellan, John A Eisman

4 Background Initial fracture increases risk of subsequent fracture and mortality Secondary fracture prevention is endorsed by national guidelines Rising call for implementing fracture liaison services (FLS) To analyze the effect of oral bisphosphonate (BP) therapy on subsequent fracture and mortality over 8-years of follow-up

5 Methods FLS of West-Glasgow health service
, men & women ≥ 50 invited Independent T-test and Chi-square test for comparing baseline characteristics Uni- and multivariable Cox proportional Hazard models Endpoints: subsequent fracture & mortality Time to fracture & death; censored at 8 years

6 5011 (53.1) fully assessed; all recommended CaD
9439 patients ≥ 50 yrs ( ) 0509 (5.4)0 reviewed 1822 (19.3) frail elderly 2097 (22.2) declined 5011 (53.1) fully assessed; all recommended CaD No additional treatment 2477 (49.4%) + oral bisphosphonates 2534 (50.6%) 293(11.8) re-fx 235 (9.5) deceased 336 (13.3) re-fx 381 (15.0) deceased P = 0.126 P < 0.001

7 Patients on BP had worse baseline characteristics
CaD alone + BP Women, % 72.4 82.9 Age, years 64.4 73.4 BMD, T-score -1.5 -3.1 Initial hip fx, % 6.2 21.2 P < 0.001 Patients on BP had worse baseline characteristics

8 Univariable model: Predictors for subsequent fractures and mortality
Gender Age BMD Fracture location Smoking Glucocorticoid use Alcohol intake ≥ 5 units per day Bisphosphonates

9 Subsequent fractures HR: 1.17 (1.00-1.36) HR: 0.60 (0.49-0.73) + BP
CaD alone Subsequent fractures Univariable Multivariable HR: 1.17 ( ) P = 0.056 HR: 0.60 ( ) P < 0.001 background methods results conclusion

10 Mortality HR: 1.64 (1.40-1.93) HR: 0.79 (0.64-0.96) + BP CaD alone
Univariable Multivariable HR: 1.64 ( ) P < 0.001 HR: 0.79 ( ) P = 0.021 background methods results conclusion

11 Conclusion Patients recommended bisphosphonates had worse baseline characteristics After adjustments, those on BP had a lower hazard for Subsequent fracture Mortality

12 Thank you for your attention!


Download ppt "Disclosure belangen NHG spreker"

Similar presentations


Ads by Google